State Street Corp Black Diamond Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 809,196 shares of BDTX stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

809,196

Previous 690,432 17.2%

Holding current value

$2.14 Million

Previous $3.22 Million 9.42%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.2 - $6.58 $498,808 - $781,467	118,764 Added 17.2%	809,196 $3.52 Million
Q2 2024 Aug 14, 2024	BUY	$4.65 - $7.39 $2.67 Million - $4.24 Million	573,348 Added 489.69%	690,432 $3.22 Million
Q1 2024 May 15, 2024	BUY	$2.67 - $5.74 $3,471 - $7,462	1,300 Added 1.12%	117,084 $593,000
Q4 2023 Feb 14, 2024	BUY	$1.77 - $3.03 $69,738 - $119,381	39,400 Added 51.58%	115,784 $325,000
Q2 2022 Aug 15, 2022	SELL	$1.5 - $3.63 $439,317 - $1.06 Million	-292,878 Reduced 79.31%	76,384 $188,000
Q1 2022 May 16, 2022	BUY	$2.66 - $5.61 $12,259 - $25,856	4,609 Added 1.26%	369,262 $1.02 Million
Q4 2021 Feb 14, 2022	BUY	$5.18 - $8.48 $46,361 - $75,896	8,950 Added 2.52%	364,653 $1.94 Million
Q3 2021 Nov 15, 2021	BUY	$8.46 - $12.42 $180,637 - $265,191	21,352 Added 6.39%	355,703 $3.01 Million
Q2 2021 Aug 16, 2021	SELL	$12.19 - $28.17 $17.8 Million - $41.1 Million	-1,460,287 Reduced 81.37%	334,351 $4.08 Million
Q1 2021 May 17, 2021	BUY	$22.23 - $34.75 $21.6 Million - $33.8 Million	972,021 Added 118.16%	1,794,638 $43.5 Million
Q4 2020 Feb 16, 2021	BUY	$29.47 - $35.0 $16 Million - $19 Million	543,698 Added 194.93%	822,617 $26.4 Million
Q3 2020 Nov 10, 2020	BUY	$26.17 - $43.07 $1.28 Million - $2.1 Million	48,801 Added 21.21%	278,919 $8.43 Million
Q2 2020 Aug 14, 2020	BUY	$22.3 - $44.8 $916,418 - $1.84 Million	41,095 Added 21.74%	230,118 $9.7 Million
Q1 2020 May 11, 2020	BUY	$18.18 - $39.48 $3.44 Million - $7.46 Million	189,023 New	189,023 $4.72 Million

Others Institutions Holding BDTX

# of Institutions

117

Shares Held

48.8M

Call Options Held

1.84M

Put Options Held

1.93M

View Full List

About Black Diamond Therapeutics, Inc.

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $95.9M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

More about BDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Black Diamond Therapeutics, Inc. Transaction History